返回期刊详情

Neuro-Oncology Advances

IF4.1

论文数1674

被引数3154

期刊论文 1674

发表时间

Performance of intraoperative AI-assisted Label-Free Stimulated Raman Histology in Recurrent Brain Tumors 术中AI辅助无标签刺激拉曼组织学在复发性脑肿瘤中的性能

Neuro-Oncology Advances

IF4.1

2026-10-29

OAAI

Gina Fürtjes; Abdulkader Al Shughri; Thomas Stehle; David Reinecke; Anna-Katharina Meißner; Nina Jung; Zeynep Mercan; Nicolas Neidert; Pierre Scheffler; Lili Leyer; Claire Wang; Zachari Gueorguiev; Niklas von Spreckelsen; Daniel Ruess; Christian Freudiger; Florian Khalid; Adrian Ion-Margineanu; Roland Goldbrunner; Jürgen Beck; Volker Neuschmelting; Jakob Straehle; null

Differentiating True Progression from Pseudoprogression in Glioblastomas: Dynamic Contrast Enhanced-MRI Habitat Analysis with Parsimonious Pharmacokinetic Model 区分胶质母细胞瘤中的真性进展与假性进展：基于简约药代动力学模型的动态对比增强MRI生境分析

Neuro-Oncology Advances

IF4.1

2026-10-29

OAAI

Sourav Basak; Subhanon Bera; Sankar Narayan Misra; Archith Rajan; Harish Poptani; Sanjeev Chawla; Sourav Bhaduri

EHMT1/2-LIG1 axis enhances Temozolomide Sensitivity in Experimental Glioma EHMT1/2-LIG1轴增强替莫唑胺在实验性胶质瘤中的敏感性

Neuro-Oncology Advances

IF4.1

2026-10-28

OAAI

Jil Trampert; Lara Annina Haeusser; Hannes Becker; Laurence Kuhlburger; Marcello Zago; Foteini Tsiami; Bianca Walter; Marko Maric; Nihal Olcay Dogan; Surender Surender; Louise Maise; Nicolas Casadei; Manfred Claassen; Sven Nahnsen; Jens Schittenhelm; Marcos Tatagiba; Susanne Beck; Daniel Josef Merk; Ghazaleh Tabatabai

Viroimmunotherapy in 9p21.3-deleted gliomas 9p21.3缺失型胶质瘤的病毒免疫疗法

Neuro-Oncology Advances

IF4.1

2026-10-24

OAAI

Andres R Lopez-Rivas; Andrew G Gillard; Claudia Solbes-Godina Riera; Dong Ho Shin; Akhila Parthasarathy; Angelis M Morales Rivera; Christopher A Alvarez-Breckenridge; Juan Fueyo; Candelaria Gomez-Manzano

Adult-Onset Giant Cell Glioblastoma with Biallelic PMS2 Inactivation in Lynch Syndrome 成人发病型巨细胞胶质母细胞瘤伴林奇综合征中PMS2双等位基因失活

Neuro-Oncology Advances

IF4.1

2026-10-23

OAAI

Muhammed Onel; Luke Gingell; Aysegul Kasay; Mohammad Muhsin Chisti

Improved efficacy of Orelabrutinib plus Rituximab, Temozolomide and High-Dose Methotrexate (RMOT) vs. RMT in untreated primary CNS lymphoma: A matched analysis 奥雷巴替尼联合利妥昔单抗、替莫唑胺和高剂量甲氨蝶呤（RMOT）与RMT方案相比在初治原发性中枢神经系统淋巴瘤中的疗效提升：一项匹配分析

Neuro-Oncology Advances

IF4.1

2026-10-12

OAAI

Peng Zhang; Man Nie; Hang Yang; Xiaojie Fang; Chengxi He; Dongyu Zhuang; Honglian Liu; Silan Huang; Dexin Lei; Qingqing Cai; Yi Xia; null

Corticosteroid treatment modulates immune cell populations in the glioblastoma microenvironment 皮质类固醇治疗调节胶质母细胞瘤微环境中的免疫细胞群体

Neuro-Oncology Advances

IF4.1

2026-10-07

OAAI

Rune Just Clausen; Sofie Sorgenfri Hjerrild Nielsen; Julie Jacobsen; Line Viftrup Buchwald; Vilde Pedersen; Nadine Margaretha Hammouda; Nicolai Schou Bager; Kirsten Grunnet; Hans Skovgaard Poulsen; Simone Maarup; Benedikte Hasselbalch; Thomas Urup; Signe Regner Michaelsen; Sara Blaabjerg Artzi; Bjarne Winther Kristensen; null

BET inhibition induces coordinated repression of the stem cell-related HOX signature in GB uncovering an epigenetic vulnerability BET抑制诱导GB中干细胞相关HOX特征的协同抑制，揭示了一种表观遗传易损性

Neuro-Oncology Advances

IF4.1

2026-10-07

OAAI

Davide Chiesi; Pierre Bady; Mihalis V Xirouchakis; Carla Mendes Ferreira; Kedir S Mohammed; Monika E Hegi

Protective effects of testosterone replacement therapy on brain tumor outcomes: the Mayo Clinic Experience 睾酮替代疗法对脑肿瘤结局的保护作用：梅奥诊所经验

Neuro-Oncology Advances

IF4.1

2026-10-07

OAAI

Manuel M Bettencourt; Shreya Gandhi; Archis Bhandarkar; Asad Lone; Gelareh Zadeh; Sheila Mansouri

Immune Subtypes and Survival in Patients with Primary Glioma 原发性胶质瘤患者的免疫亚型与生存期

Neuro-Oncology Advances

IF4.1

2026-10-05

OAAI

Yu Fang; Jiwoong Kim; Zachary J Thompson; Youngchul Kim; Harshan Ravi; Asim M Mazin; Carlos M Moran−Segura; Jonathan V Nguyen; Robert J Macaulay; Filippo Veglia; Reid C Thompson; Sajeel A Chowdhary; Kathleen M Egan; Natarajan Raghunand

EpiDirect enables rapid bisulfite-free MGMT promoter methylation testing in IDH-wildtype glioblastoma with high agreement across established assays EpiDirect实现了在IDH野生型胶质母细胞瘤中快速无亚硫酸氢钠MGMT启动子甲基化检测，且与现有检测方法具有高度一致性

Neuro-Oncology Advances

IF4.1

2026-10-05

OAAI

Attila Németh; Carmen Selignow; Annika May; Kai Schmid; Hildegard Dohmen; Marco Stein; Joshua Trautner; Daniel Haag; Felix Sahm; Till Acker

Combination chemotherapy potentiates 5-aminolevulic acid-mediated photodynamic therapy killing of patient-derived glioma stem-like cells in vitro 联合化疗增强5-氨基乙酰丙酸介导的光动力疗法对体外患者源性胶质瘤干细胞样细胞的杀伤作用

Neuro-Oncology Advances

IF4.1

2026-10-03

OAAI

Alexa M Semonche; Tatiana Slepak; Ana Pascoini; Long Di; Anna Jermakowicz; Daniel G Eichberg; Chiara Pastori; Vratko Himic; Ashish H Shah; Ricardo J Komotar; Michael E Ivan

Diagnostic Intervals in Adult Brain Tumours in Ibadan, Nigeria: A Cross-Sectional Study 尼日利亚伊巴丹成人脑肿瘤的诊断间隔：一项横断面研究

Neuro-Oncology Advances

IF4.1

2026-09-30

OAAI

Oluseyi O Agboola; Ayodeji M Adebayo; James A Balogun

The African Neuro-Oncology Access Disparity (ANAD) Index: A Public Data-Driven Approach to Mapping National Variations in Neuro-Oncology Care Barriers 非洲神经肿瘤学可及性差异（ANAD）指数：一种基于公共数据绘制神经肿瘤学护理障碍国家差异的方法

Neuro-Oncology Advances

IF4.1

2026-09-30

OAAI

Ulrick Sidney Kanmounye; Fortune Kekeli Avorgbedor; Jonathan Ayeyi Nuamah; Ernest Adu Asamoah; Shirley Sarah Dadson; Princess Yaa Benson; Emmanuella Amoako; Claire Karekezi; James Balogun; Teddy Totimeh

Management of Paediatric Low-grade glioma in Cape Town, South Africa 南非开普敦地区儿童低级别胶质瘤的管理

Neuro-Oncology Advances

IF4.1

2026-09-30

OAAI

Katlego Tsimane; Anthony Figaji; Jeannette Parkes; Komala Pillay; Alan Davidson

Burden of Pediatric Central Nervous System Tumors in Kenya: A 15-Year Histologic and Epidemiologic Analysis 肯尼亚儿童中枢神经系统肿瘤的负担：一项15年的组织学及流行病学分析

Neuro-Oncology Advances

IF4.1

2026-09-30

OAAI

Philip Mwachaka; Scott Coven; Dalton Wamalwa; Sarah Leary; Minda Okemwa

Does earlier diagnosis and treatment of brain tumours matter? Time-to-treatment intervals and tumour size at detection; impact on survival and other patient outcomes 脑肿瘤的早期诊断和治疗是否重要？治疗时间间隔和检测时肿瘤大小对生存率及其他患者结局的影响

Neuro-Oncology Advances

IF4.1

2026-09-28

OAAI

Ewan Gray; James Cameron; Abigail Lishman; Peter Hall; Piyumanga Karunaratne; Giovanni Tramonti; Maheva Vallet; Luke Pike; Matthew Baker; Paul M Brennan

Circulating Tumor DNA as a Liquid Biopsy for Glioma Detection in Cerebrospinal Fluid and Plasma: A Systematic Review and Meta-Analysis 脑脊液和血浆中循环肿瘤DNA作为胶质瘤检测的液体活检：一项系统评价和Meta分析

Neuro-Oncology Advances

IF4.1

2026-09-22

OAAI

Christian Amezquita-Contreras, M.D; Angel Bueno, M.D; Diego Arellano, M.D; Helen Ruvalcaba-Guerrero, M.D; William Johnson, B.S; Antonio Dono, M.D; Yoshua Esquenazi, M.D; Leomar Y Ballester, M.D., Ph.D

A Re-visit of Glioblastoma Molecular Subtypes Utilizing the 2021 WHO Classification of CNS Tumors Framework 利用2021年WHO中枢神经系统肿瘤分类框架重新审视胶质母细胞瘤分子亚型

Neuro-Oncology Advances

IF4.1

2026-09-22

OAAI

Geraldine Lee Wen She; M Tarek Elghetany; John Myseros; Seok-Gu Kang; Xiaonan Li; Wan-Yee Teo

Sex differences in glycine biosynthesis drives sex-specific responses to combined nutrient deprivation and pharmacological inhibition in brain tumors 脑肿瘤中甘氨酸生物合成的性别差异驱动了对联合营养剥夺和药理抑制的性别特异性反应

Neuro-Oncology Advances

IF4.1

2026-09-22

OAAI

Camryn Marquez, B.S; Jianyun Lu, Ph.D; Kevin Cho, Ph.D; Shanshan Zhang, M.S; Jingqin Luo, Ph.D; Joshua B Rubin, M.D., Ph.D; Gary J Patti, Ph.D; Joseph E Ippolito, M.D., Ph.D; null